GnRH-agonist versus GnRH-antagonist IVF cycles: is the reproductive outcome affected by the incidence of progesterone elevation on the day of HCG triggering? A randomized prospective study

Endometrial receptivity is affected in women with high circulating progesterone levels at the end of the follicular phase: a functional genomics analysis

(2011) E. Labarta et al.   HUMAN REPRODUCTION

GnRH agonist for triggering of final oocyte maturation: time for a change of practice?

(2011) P. Humaidan et al.   HUMAN REPRODUCTION UPDATE

GnRH antagonists are safer than agonists: an update of a Cochrane review

(2011) H. G. Al-Inany et al.   HUMAN REPRODUCTION UPDATE

Gonadotropin-releasing hormone agonists versus antagonists for controlled ovarian hyperstimulation in oocyte donors: a systematic review and meta-analysis

(2010) Daniel Bodri et al.   FERTILITY AND STERILITY

Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles

(2010) E. Bosch et al.   HUMAN REPRODUCTION

Progesterone rise on the day of HCG administration (premature luteinization) in IVF: An overdue update

(2010) Aboubakr M. Elnashar   JOURNAL OF ASSISTED REPRODUCTION AND GENETICS

Progesterone rise on HCG day in GnRH antagonist/rFSH stimulated cycles affects endometrial gene expression

(2010) I. Van Vaerenbergh et al.   REPRODUCTIVE BIOMEDICINE ONLINE

Progesterone rise on the day of human chorionic gonadotropin administration impairs pregnancy outcome in day 3 single-embryo transfer, while has no effect on day 5 single blastocyst transfer

(2007) Evangelos G. Papanikolaou et al.   FERTILITY AND STERILITY